Thermo Fisher agrees to acquire CorEvitas for $913m
CorEvitas will join the laboratory products and biopharma services division of Thermo Fisher.
07 July 2023
07 July 2023
CorEvitas will join the laboratory products and biopharma services division of Thermo Fisher.
The MRI software add-on differentiated patients with neurodegenerative disorders based on white matter differences.
Funds will kickstart the company’s pivotal clinical trial for its non-invasive neurostimulation device.
The test helps assess patients experiencing cognitive symptoms consistent with the early signs of AD.
The multi-application system comes with Sublime, Sublative RF and Matrix Pro applicators.
Amvia Edge is claimed to be the market’s smallest single-chamber MR conditional pacemaker.
The landscape of the medical technology industry in the UK is expected to grow following a publication of a policy paper by the British government. But what is the plan and how will medtech firms react to proposed initiatives?
South Korean company LivsMed developed the ArtiSential device.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.